Blood Biomarkers for Stroke Diagnosis and Management

Joseph Kamtchum-Tatuene; Glen C. Jickling

doi:10.1007/s12017-019-08530-0

journal article Mar 04, 2019

Blood Biomarkers for Stroke Diagnosis and Management

Joseph Kamtchum-Tatuene

Glen C. Jickling

NeuroMolecular Medicine Vol. 21 No. 4 pp. 344-368 · Springer Science and Business Media LLC

View at Publisher Save 10.1007/s12017-019-08530-0

Topics

No keywords indexed for this article. Browse by subject →

References

205

[1]

Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment.

H P Adams, B H Bendixen, L J Kappelle et al.

Stroke 1993 10.1161/01.str.24.1.35

[2]

Thrombectomy for Stroke at 6 to 16 Hours with Selection by Perfusion Imaging

Gregory W. Albers, Michael P. Marks, Stephanie Kemp et al.

New England Journal of Medicine 2018 10.1056/nejmoa1713973

[3]

Allard, L., Burkhard, P. R., Lescuyer, P., Burgess, J. A., Walter, N., Hochstrasser, D. F., et al. (2005). PARK7 and nucleoside diphosphate kinase A as plasma markers for the early diagnosis of stroke. Clinical Chemistry, 51(11), 2043–2051. https://doi.org/10.1373/clinchem.2005.053942 . 10.1373/clinchem.2005.053942

[4]

Alvarez-Perez, F. J., Castelo-Branco, M., & Alvarez-Sabin, J. (2011). Usefulness of measurement of fibrinogen, D-dimer, D-dimer/fibrinogen ratio, C reactive protein and erythrocyte sedimentation rate to assess the pathophysiology and mechanism of ischaemic stroke. Journal of Neurology, Neurosurgery, and Psychiatry, 82(9), 986–992. https://doi.org/10.1136/jnnp.2010.230870 . 10.1136/jnnp.2010.230870

[5]

Anand, N., & Stead, L. G. (2005). Neuron-specific enolase as a marker for acute ischemic stroke: A systematic review. Cerebrovascular Diseases, 20(4), 213–219. https://doi.org/10.1159/000087701 . 10.1159/000087701

[6]

Anderson, C. S., Selim, M. H., Molina, C. A., & Qureshi, A. I. (2017). Intensive blood pressure lowering in intracerebral hemorrhage. Stroke, 48(7), 2034–2037. https://doi.org/10.1161/STROKEAHA.117.016185 . 10.1161/strokeaha.117.016185

[7]

Arenillas, J. F., Alvarez-Sabin, J., Molina, C. A., Chacon, P., Fernandez-Cadenas, I., Ribo, M., et al. (2008). Progression of symptomatic intracranial large artery atherosclerosis is associated with a proinflammatory state and impaired fibrinolysis. Stroke, 39(5), 1456–1463. https://doi.org/10.1161/STROKEAHA.107.498600 . 10.1161/strokeaha.107.498600

[8]

Ariesen, M. J., Claus, S. P., Rinkel, G. J., & Algra, A. (2003). Risk factors for intracerebral hemorrhage in the general population: A systematic review. Stroke, 34(8), 2060–2065. https://doi.org/10.1161/01.STR.0000080678.09344.8D . 10.1161/01.str.0000080678.09344.8d

[9]

Atkinson, A. J., Colburn, W. A., DeGruttola, A. G., DeMets, D. L., Downing, G. J., Hoth, J. F., et al. (2001). Biomarkers and surrogate endpoints: Preferred definitions and conceptual framework. Clinical Pharmacology & Therapeutics, 69(3), 89–95. https://doi.org/10.1067/mcp.2001.113989 . 10.1067/mcp.2001.113989

[10]

Bai, J., Sun, H., Xie, L., Zhu, Y., & Feng, Y. (2018). Detection of cardioembolic stroke with B-type natriuretic peptide or N-terminal pro-BNP: A comparative diagnostic meta-analysis. International Journal of Neuroscience. https://doi.org/10.1080/00207454.2017.1408612 . 10.1080/00207454.2017.1408612

[11]

Balami, J. S., Chen, R. L., Grunwald, I. Q., & Buchan, A. M. (2011). Neurological complications of acute ischaemic stroke. The Lancet Neurology, 10(4), 357–371. https://doi.org/10.1016/S1474-4422(10)70313-6 . 10.1016/s1474-4422(10)70313-6

[12]

Balami, J. S., Hadley, G., Sutherland, B. A., Karbalai, H., & Buchan, A. M. (2013). The exact science of stroke thrombolysis and the quiet art of patient selection. Brain, 136(Pt 12), 3528–3553. https://doi.org/10.1093/brain/awt201 . 10.1093/brain/awt201

[13]

Bang, O. Y. (2017). Advances in biomarker for stroke patients: From marker to regulator. Precision and Future Medicine, 1(1), 32–42. https://doi.org/10.23838/pfm.2017.00052 . 10.23838/pfm.2017.00052

[14]

Bang, O. Y., Saver, J. L., Ovbiagele, B., Choi, Y. J., Yoon, S. R., & Lee, K. H. (2007). Adiponectin levels in patients with intracranial atherosclerosis. Neurology, 68(22), 1931–1937. https://doi.org/10.1212/01.wnl.0000263186.20988.9f . 10.1212/01.wnl.0000263186.20988.9f

[15]

Bhatia, R., Hill, M. D., Shobha, N., Menon, B., Bal, S., Kochar, P., et al. (2010). Low rates of acute recanalization with intravenous recombinant tissue plasminogen activator in ischemic stroke: Real-world experience and a call for action. Stroke, 41(10), 2254–2258. https://doi.org/10.1161/STROKEAHA.110.592535 . 10.1161/strokeaha.110.592535

[16]

Bitsch, A., Klene, W., Murtada, L., Prange, H., & Rieckmann, P. (1998). A longitudinal prospective study of soluble adhesion molecules in acute stroke. Stroke, 29(10), 2129–2135. 10.1161/01.str.29.10.2129

[17]

Bozkurt, S., Kaya, E. B., Okutucu, S., Aytemir, K., Coskun, F., & Oto, A. (2011). The diagnostic and prognostic value of first hour glycogen phosphorylase isoenzyme BB level in acute coronary syndrome. Cardiology Journal, 18(5), 496–502. 10.5603/cj.2011.0004

[18]

Briard, J. N., Zewude, R. T., Kate, M. P., Rowe, B. H., Buck, B., Butcher, K., et al. (2018). Stroke mimics transported by emergency medical services to a comprehensive stroke center: The magnitude of the problem. Journal of Stroke and Cerebrovascular Diseases, 27(10), 2738–2745. https://doi.org/10.1016/j.jstrokecerebrovasdis.2018.05.046 . 10.1016/j.jstrokecerebrovasdis.2018.05.046

[19]

Brott, T. G., Lyden, P., Grotta, J. C., Kwiatkowski, T. G., Levine, S. R., Frankel, M. R., et al. (1997). Intracerebral hemorrhage after intravenous t-PA therapy for ischemic stroke. The NINDS t-PA Stroke Study Group. Stroke, 28(11), 2109–2118. 10.1161/01.str.28.11.2109

[20]

Brunkhorst, R., Pfeilschifter, W., & Foerch, C. (2010). Astroglial proteins as diagnostic markers of acute intracerebral hemorrhage-pathophysiological background and clinical findings. Translational Stroke Research, 1(4), 246–251. https://doi.org/10.1007/s12975-010-0040-6 . 10.1007/s12975-010-0040-6

[21]

Bruns, A. H., Oosterheert, J. J., Hak, E., & Hoepelman, A. I. (2008). Usefulness of consecutive C-reactive protein measurements in follow-up of severe community-acquired pneumonia. European Respiratory Journal, 32(3), 726–732. https://doi.org/10.1183/09031936.00003608 . 10.1183/09031936.00003608

[22]

Bustamante, A., Lopez-Cancio, E., Pich, S., Penalba, A., Giralt, D., Garcia-Berrocoso, T., et al. (2017a). Blood biomarkers for the early diagnosis of stroke: The stroke-chip study. Stroke, 48(9), 2419–2425. https://doi.org/10.1161/STROKEAHA.117.017076 . 10.1161/strokeaha.117.017076

[23]

Bustamante, A., Ning, M., Garcia-Berrocoso, T., Penalba, A., Boada, C., Simats, A., et al. (2018). Usefulness of ADAMTS13 to predict response to recanalization therapies in acute ischemic stroke. Neurology, 90(12), e995–e1004. https://doi.org/10.1212/WNL.0000000000005162 . 10.1212/wnl.0000000000005162

[24]

Bustamante, A., Vilar-Bergua, A., Guettier, S., Sanchez-Poblet, J., Garcia-Berrocoso, T., Giralt, D., et al. (2017b). C-reactive protein in the detection of post-stroke infections: Systematic review and individual participant data analysis. Journal of Neurochemistry, 141(2), 305–314. https://doi.org/10.1111/jnc.13973 . 10.1111/jnc.13973

[25]

Cabral, N. L., Muller, M., Franco, S. C., Longo, A., Moro, C., Nagel, V., et al. (2015). Three-year survival and recurrence after first-ever stroke: The Joinville stroke registry. BMC Neurology, 15, 70. https://doi.org/10.1186/s12883-015-0317-1 . 10.1186/s12883-015-0317-1

[26]

Tenecteplase versus Alteplase before Thrombectomy for Ischemic Stroke

Bruce C.V. Campbell, Peter J. Mitchell, Leonid Churilov et al.

New England Journal of Medicine 2018 10.1056/nejmoa1716405

[27]

Carbone, F., Burger, F., Roversi, G., Tamborino, C., Casetta, I., Seraceni, S., et al. (2015). Leptin/adiponectin ratio predicts poststroke neurological outcome. European Journal of Clinical Investigation, 45(11), 1184–1191. https://doi.org/10.1111/eci.12538 . 10.1111/eci.12538

[28]

Castellanos, M., Castillo, J., Garcia, M. M., Leira, R., Serena, J., Chamorro, A., et al. (2002). Inflammation-mediated damage in progressing lacunar infarctions: A potential therapeutic target. Stroke, 33(4), 982–987. 10.1161/hs0402.105339

[29]

Castellanos, M., Leira, R., Serena, J., Blanco, M., Pedraza, S., Castillo, J., et al. (2004). Plasma cellular-fibronectin concentration predicts hemorrhagic transformation after thrombolytic therapy in acute ischemic stroke. Stroke, 35(7), 1671–1676. https://doi.org/10.1161/01.STR.0000131656.47979.39 . 10.1161/01.str.0000131656.47979.39

[30]

Castellanos, M., Leira, R., Serena, J., Pumar, J. M., Lizasoain, I., Castillo, J., et al. (2003). Plasma metalloproteinase-9 concentration predicts hemorrhagic transformation in acute ischemic stroke. Stroke, 34(1), 40–46. 10.1161/01.str.0000046764.57344.31

[31]

Castellanos, M., Sobrino, T., & Castillo, J. (2006). Evolving paradigms for neuroprotection: Molecular identification of ischemic penumbra. Cerebrovascular Diseases, 21(Suppl 2), 71–79. https://doi.org/10.1159/000091706 . 10.1159/000091706

[32]

Castellanos, M., Sobrino, T., Millan, M., Garcia, M., Arenillas, J., Nombela, F., et al. (2007). Serum cellular fibronectin and matrix metalloproteinase-9 as screening biomarkers for the prediction of parenchymal hematoma after thrombolytic therapy in acute ischemic stroke: A multicenter confirmatory study. Stroke, 38(6), 1855–1859. https://doi.org/10.1161/STROKEAHA.106.481556 . 10.1161/strokeaha.106.481556

[33]

Castellanos, M., Sobrino, T., Pedraza, S., Moldes, O., Pumar, J. M., Silva, Y., et al. (2008). High plasma glutamate concentrations are associated with infarct growth in acute ischemic stroke. Neurology, 71(23), 1862–1868. https://doi.org/10.1212/01.wnl.0000326064.42186.7e . 10.1212/01.wnl.0000326064.42186.7e

[34]

Castillo, J., Rama, R., & Davalos, A. (2000). Nitric oxide-related brain damage in acute ischemic stroke. Stroke, 31(4), 852–857. 10.1161/01.str.31.4.852

[35]

Chaturvedi, S., & Bhattacharya, P. (2014). Large artery atherosclerosis: Carotid stenosis, vertebral artery disease, and intracranial atherosclerosis. Continuum (Minneap Minn), 20(2 Cerebrovascular Disease), 323–334. https://doi.org/10.1212/01.CON.0000446104.90043.a5 . 10.1212/01.con.0000446104.90043.a5

[36]

Chen, X. L., Li, Q., Huang, W. S., Lin, Y. S., Xue, J., Wang, B., et al. (2017). Serum YKL-40, a prognostic marker in patients with large-artery atherosclerotic stroke. Acta Neurologica Scandinavica, 136(2), 97–102. https://doi.org/10.1111/ane.12688 . 10.1111/ane.12688

[37]

Choi, J. Y., Kim, J. S., Kim, J. H., Oh, K., Koh, S. B., & Seo, W. K. (2014). High free fatty acid level is associated with recurrent stroke in cardioembolic stroke patients. Neurology, 82(13), 1142–1148. https://doi.org/10.1212/WNL.0000000000000264 . 10.1212/wnl.0000000000000264

[38]

Crawford, F., Andras, A., Welch, K., Sheares, K., Keeling, D., & Chappell, F. M. (2016). D-dimer test for excluding the diagnosis of pulmonary embolism. Cochrane Library: Cochrane Review, 8, CD010864. https://doi.org/10.1002/14651858.CD010864.pub2 . 10.1002/14651858.cd010864.pub2

[39]

Dambinova, S. A., Khounteev, G. A., Izykenova, G. A., Zavolokov, I. G., Ilyukhina, A. Y., & Skoromets, A. A. (2003). Blood test detecting autoantibodies to N-methyl-D-aspartate neuroreceptors for evaluation of patients with transient ischemic attack and stroke. Clinical Chemistry, 49(10), 1752–1762. 10.1373/49.10.1752

[40]

Dasenbrock, H. H., Robertson, F. C., Vaitkevicius, H., Aziz-Sultan, M. A., Guttieres, D., Dunn, I. F., et al. (2017). Timing of decompressive hemicraniectomy for stroke: A nationwide inpatient sample analysis. Stroke, 48(3), 704–711. https://doi.org/10.1161/STROKEAHA.116.014727 . 10.1161/strokeaha.116.014727

[41]

Dastur, C. K., & Yu, W. (2017). Current management of spontaneous intracerebral haemorrhage. Stroke and Vascular Neurology, 2(1), 21–29. https://doi.org/10.1136/svn-2016-000047 . 10.1136/svn-2016-000047

[42]

Davalos, A., Castillo, J., Marrugat, J., Fernandez-Real, J. M., Armengou, A., Cacabelos, P., et al. (2000). Body iron stores and early neurologic deterioration in acute cerebral infarction. Neurology, 54(8), 1568–1574. 10.1212/wnl.54.8.1568

[43]

De Marchis, G. M., Katan, M., Weck, A., Fluri, F., Foerch, C., Findling, O., et al. (2013). Copeptin adds prognostic information after ischemic stroke: Results from the CoRisk study. Neurology, 80(14), 1278–1286. https://doi.org/10.1212/WNL.0b013e3182887944 . 10.1212/wnl.0b013e3182887944

[44]

De Marchis, G. M., Weck, A., Audebert, H., Benik, S., Foerch, C., Buhl, D., et al. (2014). Copeptin for the prediction of recurrent cerebrovascular events after transient ischemic attack: Results from the CoRisk study. Stroke, 45(10), 2918–2923. https://doi.org/10.1161/STROKEAHA.114.005584 . 10.1161/strokeaha.114.005584

[45]

de Oliveira Manoel, A. L., Goffi, A., Zampieri, F. G., Turkel-Parrella, D., Duggal, A., Marotta, T. R., et al. (2016). The critical care management of spontaneous intracranial hemorrhage: A contemporary review. Critical Care, 20, 272. https://doi.org/10.1186/s13054-016-1432-0 . 10.1186/s13054-016-1432-0

[46]

DeGraba, T. J., Siren, A. L., Penix, L., McCarron, R. M., Hargraves, R., Sood, S., et al. (1998). Increased endothelial expression of intercellular adhesion molecule-1 in symptomatic versus asymptomatic human carotid atherosclerotic plaque. Stroke, 29(7), 1405–1410. 10.1161/01.str.29.7.1405

[47]

del Zoppo, G. J., Levy, D. E., Wasiewski, W. W., Pancioli, A. M., Demchuk, A. M., Trammel, J., et al. (2009). Hyperfibrinogenemia and functional outcome from acute ischemic stroke. Stroke, 40(5), 1687–1691. https://doi.org/10.1161/STROKEAHA.108.527804 . 10.1161/strokeaha.108.527804

[48]

Delgado, P., Chacon, P., Penalba, A., Pelegri, D., Garcia-Berrocoso, T., Giralt, D., et al. (2012). Lipoprotein-associated phospholipase A(2) activity is associated with large-artery atherosclerotic etiology and recurrent stroke in TIA patients. Cerebrovascular Diseases, 33(2), 150–158. https://doi.org/10.1159/000334193 . 10.1159/000334193

[49]

Denorme, F., Langhauser, F., Desender, L., Vandenbulcke, A., Rottensteiner, H., Plaimauer, B., et al. (2016). ADAMTS13-mediated thrombolysis of t-PA-resistant occlusions in ischemic stroke in mice. Blood, 127(19), 2337–2345. https://doi.org/10.1182/blood-2015-08-662650 . 10.1182/blood-2015-08-662650

[50]

Dieplinger, B., Bocksrucker, C., Egger, M., Eggers, C., Haltmayer, M., & Mueller, T. (2017). Prognostic value of inflammatory and cardiovascular biomarkers for prediction of 90-day all-cause mortality after acute ischemic stroke-results from the linz stroke unit study. Clinical Chemistry, 63(6), 1101–1109. https://doi.org/10.1373/clinchem.2016.269969 . 10.1373/clinchem.2016.269969

Showing 50 of 205 references

Cited By

154

Cerebral Infarction: Epidemiology, Classification, Mechanisms, Diagnosis, and Management

Meibiao Zhang, Jianxun Hou · 2026

MedComm

Neuroinflammation in stroke—A review of implications for precision immunomodulation

Tatyana Zharikova, Elizaveta Petrova · 2026

Neuroscience

Unlocking the Potential of Stroke Blood Biomarkers: Early Diagnosis, Ischemic vs. Haemorrhagic Differentiation and Haemorrhagic Transformation Risk: A Comprehensive Review

Lazzaro di Biase, Adriano Bonura · 2023

International Journal of Molecular...

Acute Stroke Biomarkers: Are We There Yet?

Marie Dagonnier, Geoffrey A. Donnan · 2021

Frontiers in Neurology

Metrics

154

Citations

205

References

Details

Published: Mar 04, 2019
Vol/Issue: 21(4)
Pages: 344-368
License: View

Authors

J

Joseph Kamtchum-Tatuene

G

Glen C. Jickling

Funding

National Institutes of Health

Canadian Institutes of Health Research

Heart and Stroke Foundation of Canada

Cite This Article

Joseph Kamtchum-Tatuene, Glen C. Jickling (2019). Blood Biomarkers for Stroke Diagnosis and Management. NeuroMolecular Medicine, 21(4), 344-368. https://doi.org/10.1007/s12017-019-08530-0

Blood Biomarkers for Stroke Diagnosis and Management

You May Also Like